Disease/Infection News

RSS

Tulane University to receive $11.2M over seven years to establish international malaria research center

Tulane University will receive approximately $11.2 million over seven years from the National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health, to establish an International Center of Excellence in Malaria Research for West and Central Africa. The money will be awarded in response to a multi-institutional proposal from Tulane University School of Public Health and Tropical Medicine.

9 Jul 2010

HHS to give states $25 million for HIV drugs; Researchers identify antibodies that may help in AIDS vaccine research

Health and Human Services Secretary Kathleen Sebelius said Thursday "that she would provide $25 million more to help states buy life-saving medications for people with H.I.V. or AIDS. Advocates for patients said the money was not nearly enough to eliminate waiting lists, which have surged to record levels as people have lost health insurance, along with their jobs, and states have cut their budgets. Ms. Sebelius said she was 'reallocating and transferring $25 million in existing resources' to provide medicines for people on waiting lists.

9 Jul 2010

AHF: 15 Zambian health care professionals to train HIV Medics

Graduation ceremonies will be held Saturday, July 10th in Lukasa for 15 Zambian health care professionals from several districts throughout the country who have completed an educational training program administered by AIDS Healthcare Foundation. This will enable the graduates to train classes of HIV Medics to work in the country's growing fight against HIV/AIDS.

9 Jul 2010

Study on Drosophila flies may help develop treatments for serious human diseases: Article

A Science article published on July 9, 2010, describes the discovery of an alternative form of evolution that helps Drosophila flies conquer nematodes that sterilize them. Nematodes are among the most abundant, diverse and destructive parasites of plants and animals.

9 Jul 2010

NIAID announces $14M in first-year funding to establish 10 new malaria research centers

In an effort to accelerate the control of malaria and help eliminate it worldwide, the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, today announced approximately $14 million in first-year funding to establish 10 new malaria research centers around the world.

9 Jul 2010

WHO report examines donors response to developing countries during H1N1 pandemic

CIDRAP News examines a recently-released WHO report on how donor countries and organizations have responded to the needs of developing countries during the H1N1 (swine flu) pandemic. In September, the WHO estimated the "64 'least-resourced countries' needed a total of $1.48 billion of aid for vaccine, medicines and supplies, laboratory and surveillance services, communications capacity, and other activities to respond to the pandemic," according to the news service.

9 Jul 2010

Conference bursary for researchers in developing countries to attend 'Parasite to Prevention'

Today, BioMed Central announced a fund to help researchers in developing countries attend the conference, Parasite to Prevention. The conference, held in conjunction with Malaria Journal, takes place in Edinburgh UK, 20-22 October 2010.

9 Jul 2010

UC San Diego professor to establish new Peru/Brazil ICEMR to help control malaria

Tropical disease specialist Joseph Vinetz, MD, of the University of California, San Diego School of Medicine will lead an ambitious multi-national effort to help control and eventually conquer malaria, establishing a new Peruvian/Brazilian International Center of Excellence in Malaria Research Center with a seven-year, $9.2 million grant from the National Institutes of Health.

9 Jul 2010

Department of Agriculture asks consumers to discard Milky Way Farm's hard cheddar cheese

The Department of Agriculture today advised consumers who purchased aged hard cheddar cheese made with raw milk from Milky Way Farm in Troy, Bradford County, to discard the product immediately because of potential bacterial contamination. The Bureau of Food Safety has identified 20 pounds of raw milk cheddar cheese that entered the consumer market.

9 Jul 2010

MSU-led research team to create new malaria prevention, control strategies in Malawi with $9.1M federal grant

As part of a continued effort to eliminate the scourge of malaria in the southern African nation of Malawi, a Michigan State University-led research team will use a $9.1 million federal grant to create new prevention and control strategies in the small, landlocked country.

9 Jul 2010

State AIDS programs struggle as joblessness increases demand

Growing joblessness and shrinking state and federal budgets have exacerbated the financial burden on the government that provides prescription drug treatment to people with HIV/AIDS. "Now, many people with HIV are losing jobs, along with insurance, or discovering that they are infected at a time when the AIDS Drug Assistance Program — ADAP — they depend on is being overwhelmed by demands being made on it.

9 Jul 2010

IRIC scientists identify vitamin B3 as potential antifungal treatment

A team of scientists from the Institute for Research in Immunology and Cancer (IRIC) of the University of Montreal have identified vitamin B3 as a potential antifungal treatment. Led by IRIC Principal Investigators Martine Raymond, Alain Verreault and Pierre Thibault, in collaboration with Alaka Mullick, from the Biotechnology Research Institute of the National Research Council Canada, the study is the subject of a recent article in Nature Medicine.

9 Jul 2010

Media outlets examine efforts to tackle HIV/AIDS worldwide

Ahead of the International AIDS Conference, set for July 18-23 in Vienna, Austria, Reuters features an interview with Gottfried Hirnschall, the new director of the WHO's HIV Department, who speaks of the need for current funds for the global HIV/AIDS programs to be used more efficiently to achieve universal access to treatment for all HIV/AIDS patients.

9 Jul 2010

Biomagnetics, LANL collaborate to develop device for tuberculosis diagnosis

Biomagnetics Diagnostics Corp., a developer of revolutionary technology for diagnostic systems for HIV, hepatitis, tuberculosis and malaria detection, today announced the signing of an agreement with Los Alamos National Security, LLC where Los Alamos National Laboratory's scientific and engineering staffs will attempt to identify new potential human tuberculosis biomarkers and will develop a validated assay to detect human tuberculosis using a currently known biomarker to be used in combination with the waveguide-based optical biosensor platform.

9 Jul 2010

Qualaquin for treatment of night time leg cramps leads to serious side effects, FDA warns

The U.S. Food and Drug Administration today warned that the unapproved use of the malaria drug Qualaquin (quinine sulfate) to treat night time leg cramps has resulted in serious side effects and prompted the manufacturer to develop a risk management plan aimed at educating health care professionals and patients about the potential risks.

9 Jul 2010

PharmAthene reports progress in lyophilized rPA anthrax vaccine development program

PharmAthene, Inc., a biodefense company developing medical countermeasures against biological and chemical threats, announced today that it continues to make solid progress in its lyophilized recombinant Protective Antigen (rPA) anthrax vaccine development program. The Company has recently demonstrated that its lyophilized rPA vaccine candidate is structurally stable and potent at various temperatures up to and including 70 degrees centigrade.

9 Jul 2010

Roche Molecular Systems receives FDA clearance for new LightCycler MRSA Advanced Test

Roche Molecular Systems, Inc. announced today that the U.S. Food & Drug Administration (FDA) cleared its new LightCycler® MRSA Advanced Test for the detection of methicillin-resistant Staphylococcus aureus (MRSA) for clinical use in the United States.

9 Jul 2010

Advanced Life Sciences announces positive results from preclinical studies of Restanza IV

Advanced Life Sciences Holdings, Inc., a biopharmaceutical company engaged in the discovery, development and commercialization of novel drugs in the therapeutic areas of infection, oncology and respiratory diseases, today announced positive results from preclinical toxicology and pharmacokinetic studies of an intravenous (IV) formulation of its novel antibiotic, Restanza™ that support its use in a hospital setting.

8 Jul 2010

Experts to sound alarm on the worsening global AIDS crisis among MSM

Many of the world's leading experts on the health and human rights of men who have sex with men (MSM) will gather on Tuesday, July 20 for a press briefing to sound the alarm on the worsening global AIDS crisis among MSM -- and the role that tragic human rights violations and ignorance play in the spread of the epidemic.

8 Jul 2010

Vitamin D receptor emerges as key player amid gut bacteria, scientists find

Within the human digestive tract is a teeming mass of hundreds of types of bacteria, a potpourri of microbes numbering in the trillions that help us digest food and keep bad bacteria in check.

8 Jul 2010

Disease/Infection News

Tulane University to receive $11.2M over seven years to establish international malaria research center

HHS to give states $25 million for HIV drugs; Researchers identify antibodies that may help in AIDS vaccine research

AHF: 15 Zambian health care professionals to train HIV Medics

Study on Drosophila flies may help develop treatments for serious human diseases: Article

NIAID announces $14M in first-year funding to establish 10 new malaria research centers

WHO report examines donors response to developing countries during H1N1 pandemic

Conference bursary for researchers in developing countries to attend 'Parasite to Prevention'

UC San Diego professor to establish new Peru/Brazil ICEMR to help control malaria

Department of Agriculture asks consumers to discard Milky Way Farm's hard cheddar cheese

MSU-led research team to create new malaria prevention, control strategies in Malawi with $9.1M federal grant

State AIDS programs struggle as joblessness increases demand

IRIC scientists identify vitamin B3 as potential antifungal treatment

Media outlets examine efforts to tackle HIV/AIDS worldwide

Biomagnetics, LANL collaborate to develop device for tuberculosis diagnosis

Qualaquin for treatment of night time leg cramps leads to serious side effects, FDA warns

PharmAthene reports progress in lyophilized rPA anthrax vaccine development program

Roche Molecular Systems receives FDA clearance for new LightCycler MRSA Advanced Test

Advanced Life Sciences announces positive results from preclinical studies of Restanza IV

Experts to sound alarm on the worsening global AIDS crisis among MSM

Vitamin D receptor emerges as key player amid gut bacteria, scientists find

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News